NASDAQ: RPRX · Life Sciences · 6 alerts · CIK 1802768
Share price
$68.53Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Royalty Pharma plc filings on SEC EDGAR ↗
Royalty Pharma EVP, Research & Investments Marshall Urist Sells $236K of Stock
Marshall Urist, EVP, Research & Investments, sold 4,126 shares of Royalty Pharma plc at $57.10 a share, worth $236K in total on Oct 5, 2026. Shares held after the trade: 0 (-100.0%).
Royalty Pharma EVP, Research & Investments Marshall Urist Sells $239K of Stock
Marshall Urist, EVP, Research & Investments, sold 4,126 shares of Royalty Pharma plc at $57.88 a share, worth $239K in total on Sep 28, 2026. Shares held after the trade: 4,126 (-50.0%).
Royalty Pharma EVP & Chairman, Partnering Christopher Hite Sells $5.85M of Stock
Christopher Hite, EVP & Chairman, Partnering, sold 100,000 shares of Royalty Pharma plc at $58.51 to $58.93 a share (average $58.53) in 2 transactions, worth $5.85M in total on Sep 22, 2026. Shares held after the trade: 270,401 (-1.4%).